产品分类
Product Category详细介绍
| 品牌 | absin | CAS | 205678-31-5 |
|---|---|---|---|
| 分子式 | C22H24F3N3O4 | 纯度 | 98% |
| 分子量 | 451.44 | 货号 | abs47028306 |
| 规格 | 5mg | 供货周期 | 现货 |
| 主要用途 | is a potent integrin inhibitor | 应用领域 | 化工,生物产业,农林牧渔,制药/生物制药,综合 |
SB273005 205678-31-5
| 产品描述 | |
| 描述 | SB273005 is a potent integrin inhibitor with Ki of 1.2 nM and 0.3 nM for αvβ3 receptor and αvβ5 receptor, respectively. |
| 纯度 | 98% |
| 储存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 可溶性/溶解性 | DMSO:90 mg/mL warmed (199.36 mM) |
| 生物活性 | |
| 靶点 | αvβ5 receptor ,αvβ3 receptor |
| In vitro(体外研究) | In vitro, SB273005 inhibits human osteoclast-mediated bone resorption with IC50 of 11 nM. In blood containing MDA-MB-231 cells, a combination of SB273005 and lamifiban inhibits tumor cell adhesion to vascular extracellular matrix (ECM). |
| In vivo(体内研究) | In rat models of bone resorption and osteoporosis, SB273005 (30 mg/kg, p.o.) inhibits the parathyroid hormone-stimulated calcemic response, and inhibits bone loss. In rat with adjuvant-induced arthritis, SB273005 (60 mg/kg, p.o.) significantly reduces the symptoms of adjuvant-induced arthritis. SB273005 (1000 mg/kg/day, p.o.) causes acute, transient necrosis of vascular smooth muscle cell (VSMC) in aorta and renal arteries of mice. In pregnant mice, SB273005 reverses the reduction of Th1 cell-produced IL-2 levels and the increase of Th2 cell-derived IL-10 levels. |
| 参考文献 | |
| 参考文献 |
| 研究领域 | |
| 研究领域 | Signal TransductionCytoskeleton / ECMCytoskeleton Drug DiscoverySmall Molecule DrugLead Compound Discovery |
产品咨询